Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study.

MLA

Sandersleben, Henrik Uebel-von, et al. “Effectiveness and Safety of Dexamphetamine Sulfate (Attentin®) in the Routine Treatment of Children and Adolescents with ADHD: Results from a 12-Month Non-Interventional Study.” Scandinavian Journal of Child & Adolescent Psychiatry & Psychology, vol. 9, Jan. 2021, pp. 73–86. EBSCOhost, https://doi.org/10.21307/sjcapp-2021-009.

APA

Sandersleben, H. U., Dangel, O., Fischer, R., Ruhmann, M., & Huss, M. (2021). Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study. Scandinavian Journal of Child & Adolescent Psychiatry & Psychology, 9, 73–86. https://doi.org/10.21307/sjcapp-2021-009

Chicago

Sandersleben, Henrik Uebel-von, Oliver Dangel, Roland Fischer, Michaela Ruhmann, and Michael Huss. 2021. “Effectiveness and Safety of Dexamphetamine Sulfate (Attentin®) in the Routine Treatment of Children and Adolescents with ADHD: Results from a 12-Month Non-Interventional Study.” Scandinavian Journal of Child & Adolescent Psychiatry & Psychology 9 (January): 73–86. doi:10.21307/sjcapp-2021-009.